Brucellosis diagnostic criteria

Brucellosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Brucellosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Principles of diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X-Ray
CT Scan
MRI
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Brucellosis diagnostic criteria On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Brucellosis diagnostic criteria All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Brucellosis diagnostic criteria
CDC on Brucellosis diagnostic criteria
Brucellosis diagnostic criteria in the news
Blogs on Brucellosis diagnostic criteria
Directions to Hospitals Treating Brucellosis
Risk calculators and risk factors for Brucellosis diagnostic criteria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Danitza Lukac

Overview

The diagnosis of brucellosis is based on the clinical and laboratory criteria.

Diagnostic Criteria

• Clinical Description
  • An illness characterized by acute or insidious onset of fever and one or more of the following:
    • Night sweats
    • Arthralgia
    • Headache
    • Fatigue
    • Anorexia
    • Myalgia
    • Weight loss
    • Arthritis/spondylitis
    • Meningitis
    • Focal organ involvement (endocarditis, orchitis/epididymitis, hepatomegaly, splenomegaly)
• Laboratory Criteria for Diagnosis
  • Definitive:
    • Culture and identification of Brucella spp. from clinical specimens
    • Evidence of a fourfold or greater rise in Brucella antibody titer between acute- and convalescent-phase serum specimens obtained greater than or equal to 2 weeks apart
  • Presumptive:
    • Brucella total antibody titer of greater than or equal to 160 by standard tube agglutination test (SAT) or Brucella microagglutination test (BMAT) in one or more serum specimens obtained after onset of symptoms
    • Detection of Brucella DNA in a clinical specimen by PCR assay

Case Classification

• Probable
  • A clinically compatible illness with at least one of the following:
    • Epidemiologically linked to a confirmed human or animal brucellosis case
    • Presumptive laboratory evidence, but without definitive laboratory evidence, of Brucella infection
• Confirmed
  • A clinically compatible illness with definitive laboratory evidence of Brucella infection